Inventor · disambiguated record
Bokyung Min
Also filed as: MIN BOKYUNG
3 granted patents·9 pending applications·16 citations·filing 2012–2024
59Inventor score
Files withARTIVA BIOTHERAPEUTICS INC5GC CELL CORP4GREEN CROSS LAB CELL CORP2MOGAM BIOTECHNOLOGY INST1
Top patents by PatentIndex Score
12 records- 0182US9834753B2Method for producing natural killer cells, natural killer cells produced thereby, and composition for treating cancers and infectious diseases containing the sameMOGAM BIOTECHNOLOGY INST·Filed 2012·Granted Dec 5, 2017·16 cites·9 claims
- 0271US2025109380A1Method for culturing natural killer cell, using transformed t cellGC CELL CORP·Filed 2024·Application pending·0 cites
- 0365US2023108578A1Medium Composition for Cryopreservation of Cell and Use ThereofGC CELL CORP·Filed 2022·Application pending·0 cites
- 0462US2025243461A1Method for introducing target gene into immune cellsGC CELL CORP·Filed 2023·Application pending·0 cites
- 0560US12203065B2Method for culturing natural killer cell, using transformed T cellGC CELL CORP·Filed 2018·Granted Jan 21, 2025·0 cites·30 claims
- 0658US2024424099A1Treatment of cancer with nk cells and multispecific engagersARTIVA BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0748US2024366664A1Treatment of cancer with nk cells and an egfr targeted antibodyARTIVA BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0848US2024197778A1Treatment of cancer with nk cells and a her2 targeted antibodyARTIVA BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0947US2024000840A1Treatment of cancer with nk cells and a cd20 targeted antibodyARTIVA BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1047US2024060046A1Expanded and stimulated natural killer cellsARTIVA BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1145US2019037831A1Medium composition for cryopreservation of cell and use thereofGREEN CROSS LAB CELL CORP·Filed 2017·Application pending·0 cites
- 1243US12398372B2Method for culturing cord blood-derived natural killer cells using transformed T-cellsGREEN CROSS LAB CELL CORP·Filed 2019·Granted Aug 26, 2025·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Bokyung Min files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →